Goldman Sachs’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1,000K | Buy |
861,767
+405,374
| +89% | +$470K | ﹤0.01% | 3843 |
|
|
2025
Q1 | $726K | Sell |
456,393
-461,714
| -50% | -$734K | ﹤0.01% | 4028 |
|
|
2024
Q4 | $2.78M | Buy |
918,107
+284,043
| +45% | +$861K | ﹤0.01% | 3275 |
|
|
2024
Q3 | $2.33M | Buy |
634,064
+14,811
| +2% | +$54.5K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $2.53M | Buy |
619,253
+287,253
| +87% | +$1.17M | ﹤0.01% | 3046 |
|
|
2024
Q1 | $5.23M | Buy |
332,000
+39,119
| +13% | +$617K | ﹤0.01% | 2531 |
|
|
2023
Q4 | $4.44M | Buy |
292,881
+69,620
| +31% | +$1.05M | ﹤0.01% | 2683 |
|
|
2023
Q3 | $4.48M | Sell |
223,261
-510,316
| -70% | -$10.2M | ﹤0.01% | 2557 |
|
|
2023
Q2 | $20.7M | Buy |
733,577
+529,631
| +260% | +$14.9M | ﹤0.01% | 1528 |
|
|
2023
Q1 | $3.51M | Sell |
203,946
-186,436
| -48% | -$3.21M | ﹤0.01% | 2807 |
|
|
2022
Q4 | $7.86M | Buy |
390,382
+52,050
| +15% | +$1.05M | ﹤0.01% | 2304 |
|
|
2022
Q3 | $7.33M | Sell |
338,332
-59,238
| -15% | -$1.28M | ﹤0.01% | 2365 |
|
|
2022
Q2 | $11.2M | Buy |
397,570
+132,324
| +50% | +$3.72M | ﹤0.01% | 2041 |
|
|
2022
Q1 | $12.2M | Buy |
265,246
+123,877
| +88% | +$5.72M | ﹤0.01% | 2070 |
|
|
2021
Q4 | $11.9M | Sell |
141,369
-88,972
| -39% | -$7.48M | ﹤0.01% | 2141 |
|
|
2021
Q3 | $15.4M | Buy |
230,341
+146,052
| +173% | +$9.73M | ﹤0.01% | 1929 |
|
|
2021
Q2 | $4.48M | Buy |
84,289
+32,480
| +63% | +$1.73M | ﹤0.01% | 2858 |
|
|
2021
Q1 | $2.25M | Sell |
51,809
-172,174
| -77% | -$7.47M | ﹤0.01% | 3277 |
|
|
2020
Q4 | $11.6M | Buy |
223,983
+191,812
| +596% | +$9.96M | ﹤0.01% | 1952 |
|
|
2020
Q3 | $1.05M | Buy |
32,171
+18,351
| +133% | +$600K | ﹤0.01% | 3281 |
|
|
2020
Q2 | $664K | Buy |
+13,820
| New | +$664K | ﹤0.01% | 3455 |
|